Dr. Paul Earley has been an Addiction Medicine Physician for 36 years. He treats all types of addictive disorders and specializes in the assessment and treatment of health care professionals. As a therapist, he works with patients already in recovery, providing long-term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. Dr. Earley is a Distinguished Fellow of ASAM and has been on the board of ASAM for over 20 years in several capacities. He has been the Medical Director of two nationally acclaimed addiction programs specializing in healthcare professionals who suffer from addiction illnesses. Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia in the U.S. With Earley Consultancy, LLC, he works with numerous treatment facilities, providing training in cohesive care, treatment effectiveness, and staff development.

Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified in Addiction Medicine by the American Board of Preventive Medicine, as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.

Dr. Salsitz is a course director for ASAM sponsored Buprenorphine and REMS Opioid trainings, and is a lead mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee.

Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.
Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.

Ricardo Restrepo, MD, MPH finished his medical school in Medellín, Colombia. He then did his residency training in Psychiatry at Boston University Medical Center where he completed a fellowship in Addiction Psychiatry. He received an MPH in Global Public Health from NYU in 2008, while working at St Luke’s/Roosevelt Hospital, where he was Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York. 

Since 2012, he works at the Long Beach VA Hospital, where he is the Medical Director of the SATP/Buprenorphine Clinic. Ricardo holds an academic position as Associate Clinical Professor of Psychiatry at the University of California (Irvine and Riverside) School of Medicine and most recently at the Charles Drew University, Los Angeles. He teaches and supervises students, psychiatry, family medicine and internal medicine residents. He serves as committee member of the American Academy of Addiction Medicine (AAAP) as well as on the California Society of Addiction Medicine (CSAM) Conference planning committee. 

 Ricardo's academic interests include the psychotherapy and psychopharmacology of addiction and the teaching of Psychiatry and Addiction Medicine. He is actively involved in issues related to transcultural psychiatry and behavioral addictions. He has worked with immigrant populations in the United States for over 20 years. As a volunteer for Physicians for Human Rights (PHR), he has participated in projects in the United States, Latin America and the Middle East. He has served as a United Nations Consultant since 2005. 

Dr. Restrepo has written chapters on addiction and human rights textbooks. He is the co-author of textbooks on buprenorphine as well as women’s health and addiction, and he cooperated with the Translation of DSM-5 to Spanish. He is board re-certified in Psychiatry and Addiction Psychiatry and a professional musician.

Soteri Polydorou, MD is a practicing physician with board certifications in Addiction Medicine and Internal Medicine.  His involvement in the field of substance use disorder (SUD) treatment and education include serving as Medical Director of Addiction Services for Northwell Health and Associate Professor at the Zucker School of Medicine at Hofstra/Northwell.  Northwell Health is a regional health system of over 20 hospitals and nearly 800 outpatient facilities.  Dr. Polydorou is a member of various governmental and professional committees tasked with supporting the delivery and organization of addiction treatment.  Dr. Polydorou’s interests include public policy initiatives to address substance use disorders, optimizing access to SUD services within health systems, and implementation of innovative opioid use disorder treatments within various healthcare clinical settings.

Jonathan Avery, MD is currently the Director of Addiction Psychiatry and an Associate Professor of Clinical Psychiatry at Weill Cornell Medical College and New York-Presbyterian Hospital. In addition to his clinical work, Dr. Avery teaches addiction psychiatry to the Weill Cornell medical students and residents of New York-Presbyterian Hospital. He has been published on a broad variety of topics in psychiatry, including papers on subjects ranging from clinician attitudes towards patients to how to use buprenorphine. He is the founder of the Addiction Stigma Institute that studies stigma towards individuals with substance use disorders and creates novel interventions to improve these stigmatizing attitudes. He was on the editorial board for the DSM-5 Clinical Cases book and is the editor of the books Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment and The Stigma of Addiction: An Essential Guide. He has won numerous awards for his clinical and academic work, including the American Board of Psychiatry and Neurology Faculty Innovation in Education Award and the Outstanding Faculty Member Award from the New York County Psychiatric Society.

Dr. Mashal Khan is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine-NewYork Presbyterian Hospital. He attended the School of Medicine at Xi'an Jiaotong University and trained at Maimonides Medical Center, where he served as Chief Resident. Following his residency training, he completed a Fellowship in Addiction Psychiatry at Icahn School of Medicine at Mount Sinai. He is board certified in General Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology. Dr. Khan works along with the the Liver transplant team and focuses on improving outcomes for individuals with alcohol use disorder and related liver disease.

Annie Levesque, MD, MSc, FASAM is the Medical Director of the Opioid Treatment Program at the Addiction Institute at Mount Sinai West. She is also the Associate Director of the Fellowship in Addiction Medicine Program at the Icahn School of Medicine at Mount Sinai. After receiving her medical degree from the University of Montreal, Dr. Levesque completed a Family Medicine and a Clinician-Scholar residency program at the University of Montreal, an Addiction Medicine fellowship at Mount Sinai West Hospital and a Masters in Experimental Medicine at McGill University

Faye Chao, MD is the unit chief of the inpatient addiction services at Mount Sinai West Hospital. She attended Jefferson Medical College in Philadelphia and completed her general psychiatry residency training at Harvard Longwood. She went on to an addiction psychiatry fellowship at NYU, and after fellowship, she worked at Bellevue Hospital for 1.5 years before moving on to her current position. She is board certified in both General and Addiction Psychiatry. Within the field of psychiatry, her interests include internet addiction and the management of pain in the addicted population.

Jeffrey DeVido, MD, MTS, FASAM, FAPA is board certified in General Psychiatry, Addiction Psychiatry, and Addiction Medicine and works in Northern California. Upon completion of residency and fellowship training at Massachusetts General and McLean Hospitals/Partners Healthcare, he attended on the psychaitric consultation-liaison service at UCSF, Parnassus Campus for 3 years. For the past 5 years, Dr. DeVido has been Chief of Addiction Services with Marin County, CA, Department of Health and Human Services and Behavioral Health Clinical Director with Partnership HealthPlan of CA. In both of these roles, he is involved in managing the development of substance use and co-occurring services for Medicaid beneficiaries in 14 counties between the Oregon border and San Francisco. In his free time, he enjoys fly fishing, chasing around his 3 young kids, watercolor painting, Philadelphia sports, and Star Trek.

Dr. Leslie Hayes, MD, works for El Centro Family Health in Espanola, NM. She is board-certified in both addiction and family medicine. While Dr. Hayes enjoys all aspects of family medicine, her particular passion is taking care of people with opioid use disorder. She especially enjoys working with pregnant women and new mothers who have had drug problems and works hard to make sure that they and their babies receive compassionate and appropriate medical care. She got much of her training in substance use disorders through Project ECHO and now considers herself extremely fortunate to have been able to give back to Project ECHO, and she now provides training for other providers around the state of New Mexico and nationally in substance use disorder and use of buprenorphine. She recently started an ECHO in her own organization with the goal of getting 90% of providers trained to prescribe buprenorphine and provide compassionate, evidence-based care for Substance Use Disorder. She was named a White House Champion of Change in April of 2016 for her work with substance use disorder and pregnancy. Her work was also featured in The Providers, an award-winning documentary about rural health care.

Dr. Nelson is Professor and Chair of the Department of Emergency Medicine and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School in Newark, NJ. He is a member of the Board of Directors of the American Board of Emergency Medicine and a Past-President of the American College of Medical Toxicology. He remains actively involved with CDC, FDA, DHS, and with several professional medical organizations including ASAM. Dr. Nelson is an editor of the textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several journals. In addition to providing direct clinical care to patient in the ED and his efforts at New Jersey Poison Information & Education System, his specific expertise include the consequences of licit and illicit opioids, emerging drugs of abuse, opioid stewardship, and alcohol withdrawal.

Carolyn Warner-Greer, MD, FASAM is originally from Portland, Oregon. She is a graduate of Ball State University and Indiana University School of Medicine. She is board certified in obstetrics-gynecology and addiction medicine and currently is a physician at the Bowen Center and the medical director of the Bowen Recovery Center. She is the Immediate-Past President of the Indiana Chapter of the American Society of Addiction Medicine and speaks frequently on all topics of medical treatment of mental health and addiction recovery. She participates in Allen County Overdose Fatality Review Team, Indiana University School of Medicine Project ECHO as well as the Maternal Child Substance Use Disorder Network. She has worked extensively in forensic diversion as well as women’s health care and preventative community programming. She lives in Fort Wayne with her husband, Jerry, and their four children.

Dr. Mason Turner is the Associate Chief Medical Officer for Behavioral Health for Intermountain Health based in Salt Lake City, UT and Denver, CO.
His leadership in mental health care focuses on the development and evolution of strategic innovations in behavioral health care delivery that enhance quality of care and clinical excellence and are guided by principles of equity and inclusion of the patient/consumer voice into all aspects of the behavioral health ecosystem.
Including integration initiatives which link mental health care and addiction medicine services with both primary and specialty medical care, as well as supporting innovative technological means of reaching patients for treatment of behavioral health conditions, he is also committed to enhancing access for behavioral health care services to all those who need it. Additionally, he has extensive experience in promoting employee health and well-being in a variety of corporate and healthcare sectors.
As a clinician, he specializes in addiction medicine, consult-liaison psychiatry and treatment of personality disorders. He has received extensive training in resiliency-and systems-based approaches for improving the mental health and well-being of refugees, asylum seekers and torture survivors.
Dr. Turner also served as a former Assistant Clinical Professor in Psychiatry at the University of California, San Francisco Medical School, where he taught medical students at all levels the practice of interviewing patients and clinical reasoning skills. He also served as adjunct faculty at the University of Hawaii John A. Burns School of Medicine.
Dr. Turner earned his AB degree in psychology from Dartmouth College in Hanover, NH, and completed his MD degree at the University of Texas, Southwestern Medical Center/ Parkland Hospital in Dallas, TX. He completed his residency in psychiatry at Harvard University Medical School through Massachusetts General Hospital and McLean Hospital, in Boston, MA, with additional training in psychotherapy at the Center for Psychoanalytic Studies at Massachusetts General Hospital and addiction psychiatry at McLean Hospital. He is board certified in Psychiatry and Addiction Medicine through the American Board of Preventive Medicine.

Dr. Michael Fingerhood is an Associate Professor of Medicine and Public Health at the Johns Hopkins University. He is the Chief of the Division of Chemical Dependence and medical director of the Comprehensive Care Practice (CCP) at Johns Hopkins Bayview Medical Center. The CCP integrates substance use disorder treatment with primary medical care, including care for HIV and hepatitis C.

Eve Lasswell, PsyD, is a licensed clinical psychologist who treats adults with substance use and co-occurring disorders. Dr. Lasswell is part of UC San Diego Health's Addiction Recovery and Treatment Services, which uses a harm-reduction approach to provide care for all stages of recovery from substance use disorders. She treats patients with co-occurring mental health and substance abuse disorders and helps adults recover from addiction by encouraging behaviors that build wellness and emotional resilience.

 In addition, she has experience helping people with post-traumatic stress disorder (PTSD), depression, and anxiety, as well as concerns related to role transitions and interpersonal relationships.

 Dr. Lasswell also has experience providing care to diverse patient populations, including those with ethnic backgrounds different from her own, LGBTQIA (lesbian, gay, bisexual, transgender, queer or questioning, intersex, and asexual) individuals, and current and former members of the US military.

 Her research aims to improve outcomes for people with substance use disorders and improving access to mental health services for the underserved.

 Dr. Lasswell completed a postdoctoral fellowship in addiction treatment at Veterans Affairs Salt Lake City Health Care System. She earned her doctorate in clinical psychology at Indiana State University.

 She is a member of the American Psychological Association's Society of Addiction Psychology.

Amutha Rajagopal, MD, is a board-certified internal medicine, infectious diseases and addiction medicine specialist. She is a part of UC San Diego Health's Owen Clinic, one of the nation's outstanding primary care centers for HIV positive individuals and consults in UC San Diego Health hospitals. Dr. Rajagopal also holds a master's degree in public health with an emphasis in epidemiology.

Dr. Kan graduated from Northwestern University Medical School. He finished his General Psychiatry Residency and Forensic Psychiatry Fellowship at the University of California, San Francisco (UCSF). He is Board-certified by the American Board of Psychiatry and Neurology in General and Forensic Psychiatry and he is Board-Certified by the American Board of Addiction Medicine in Addiction Medicine. He is a member of the faculty at the UCSF Department of Psychiatry.

Dr. Kan enjoys teaching, in addition to his direct work with patients. He has won multiple awards for teaching and clinical care delivery. Dr. Kan teaches and supervises psychiatrists-in-training in his role as a faculty member at UCSF. Throughout the year, he speaks at professional conferences on topics including treatment of addictive disorders.

Dr. Kan offers forensic consulting services to courts and attorneys in civil, criminal, and administrative matters. He has testified in multiple states, counties and federal court as an expert witness. He is a member of the American Academy of Psychiatry and the Law.

Dr. Kan works in private practice and is the Chief Medical Officer of Bright Heart Health. Bright Heart Health's mission is to provide high-quality addiction treatment via telemedicine to all.

Dr. Kan is an active member of the California Society of Addiction Medicine (CSAM). CSAM is a physician organization dedicated to improving the treatment of substance use disorders. Dr. Kan has planned conferences and spoken to many physician and non-physician groups. Dr. Kan is a Past President of CSAM. Dr. Kan is a Distinguished Fellow of the American Society of Addiction Medicine (D.F.A.S.A.M.).

Dr. Kan has testified numerous times before the California Assembly and Senate on addiction treatment. Dr. Kan has testified before Congress advocating for expanding access to addiction treatment.

David Galbis-Reig MD, FASAM received his Doctor of Medicine degree from Virginia Commonwealth University in Richmond, Virginia in 1999. He completed a residency in Internal Medicine at Aurora Sinai Medical Center in Milwaukee, Wisconsin in 2004. He is board certified in Internal Medicine by the American Board of Internal Medicine and Addiction Medicine by the American Board of Addiction Medicine. He has been the Director of Medical Services on the Inpatient Mental Health and Addiction Unit at Wheaton Franciscan Healthcare – All Saints since 2005 in which capacity he has passionately advocated for appropriate medical treatment of patients with mental health and addictive diseases. Dr. Galbis-Reig is currently also involved in numerous educational activities to decrease prescription drug abuse and decrease the burden of addiction to opioids in Racine and Kenosha Counties. He is an active member of the American Society of Addiction Medicine (ASAM), the current secretary of the Wisconsin Society of Addiction Medicine (WiSAM), and a contributing author to the recently published ASAM white paper on the science of drug testing. He is a member of the Wisconsin Marijuana Prevention Ad-Hoc Committee of the State Council on Alcohol and Other Drug Abuse (SCAODA). He is also an active member of the Wisconsin Medical Society and a member of the Board of Directors of the Wisconsin Medical Society Foundation.

Dr. Goldsmith began his addiction medicine career in 1974 as a medical student, learning about the disease of alcoholism as a counselor for one of the Department of Transportation's Alcohol Safety Action Projects. He received his medical training and finished his residency in Psychiatry at the University of Cincinnati College of Medicine. Dr. Goldsmith worked in the VA for 15 years, splitting his time between Dual Diagnosis Services, psychiatric consultations and research with the Clinical Trials Network. He was an active member of Cincinnati's NIDA research group, and Cincinnati's principal investigator for its pivotal study of buprenorphine/naloxone for opiate addiction. Dr Goldsmith also created an integrated Primary Care Mental Health program with the director of Primary Care, initiated in 2007 and still active. Prior to retiring, Dr. Goldsmith worked in the VA Buprenorphine Treatment Clinic.

In 1994, Dr. Goldsmith developed an ACGME accredited Addiction Psychiatry Fellowship and the following year was funded by the Dept. of Veterans Affairs for a two year Addiction Medicine Fellowship. He holds the title of Professor of Clinical Psychiatry in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati. He was addiction fellowship director from 1989 to 2007 and continues to teach in addiction fellowships: Psychiatry and ABAM.

Dr. Goldsmith joined ASAM in 1984, became ASAM certified in 1986 and got his CAQ in Addiction Psychiatry in 1994. He has been on the CME committee since then, and was its chair for nine years from 2000-2009. Dr Goldsmith was President of ASAM 2015-2017.

Dr. Soumya L. Pandalai is a board certified physician in the field of Internal Medicine and Addiction Medicine. She currently works at Banner University Medical Center Phoenix (BUMCP) in Phoenix, Arizona as a specialist in Addiction Medicine and provides both inpatient consultation services and outpatient treatmentr to persons with Substance Use Disorders (SUDs). Dr. Pandalai enjoys the clinical practice of Addiction Medicine and finds the neuroscience of addiction to be intellectually stimulating and challenging to observe the health-effects that can result from various aspects of human behavior. It is also immensely rewarding to connect with patients at different stages of their recovery process and help them along their path toward healing. She hopes to inspire people to view addiction from a different lens and apply principles of substance use and reward pathways to general aspects of human motivation and other medical illnesses. Dr. Pandalai is proud and grateful to work with an interdisciplinary team of hospital staff, social workers, counselors and other medical providers to create a more inclusive and health-focused model for substance use treatment, chronic pain and use of treatment options like tele-health to advance the care of vulnerable patient populations.

Dr. Hiroko Furo is an Associate Professor ofAddiction Medicine at Baylor College of Medicine. She is board-certified inAddiction Medicine, Occupational Medicine, and Lifestyle Medicine, and isboard-eligible in Clinical Informatics. During her fellowship in MedicalToxicology at SUNY Upstate Medical University, she developed a strong interestin addiction medicine. She holds a PhD in Sociolinguistics from Georgetown Universityand an MD from the University of Illinois College of Medicine.

Dr. Furo’s clinical experience spans opioidtreatment programs, outpatient addiction care, emergency department/inpatientconsultation, and residential detox settings. Her research focuses on urinedrug testing, social determinants of health, and research informatics. Shehas authored numerous articles in peer-reviewed journals and presentedher research at various scientific conferences. She also serves asaffiliated faculty in Addiction Medicine at SUNY Buffalo.

Dr. Hunter is the Medical Director of Addiction Medicine at United Health Services Hospitals, Inc. (UHS). Under her leadership, her department embraces evidence-based practices and harm reduction principles in its low-threshold buprenorphine program, opioid treatment program, and 20-bed inpatient unit.  She teaches residents at UHS in psychiatry, family medicine, and internal medicine, and is the methadone site director for Geisinger’s addiction medicine fellowship.  She is pleased to participate in the American Society of Addiction Medicine’s Board Exam Study Tool Subcommittee, the New York State Department of Health AIDS Institute Substance Use Guidelines Committee, the New York State Advisory Group on Hepatitis C Treatment Among People Who Inject Drugs, and the New York State Department of Health’s Buprenorphine Working Group.

She is board certified in addiction and family medicine.  She graduated from Harvard University with honors with a bachelor’s in history, and graduated from Dartmouth College with a master of public health. After attending SUNY Upstate Medical University, she completed her family medicine residency at the University of Vermont and her addiction medicine fellowship at Summa Health.

Dr. Ahmed is triple board-certified in Adult Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology, and in Addiction Medicine by the American Board of Preventive Medicine. He has extensive experience treating psychiatric and substance use disorders in both inpatient and outpatient settings. Additionally, he is actively involved in clinical research and teaching.